BridgeMD
New treatment option for Breast Cancer
Official title Who and Why do Patients Report Lymphedema After Breast Cancer Treatment Without an Objective Measurable Swelling
ClinicalTrials.gov ID: NCT06324721
What this study is testing
- What it's testing
- Breast cancer related lymphedema (BCRL) at the arm and/or trunk is an extremely dreaded complication after breast cancer treatment due to its chronicity and impact. The incidence of objective arm and trunk/ breast BCRL is declining due to the major shift into the treatment approach of breast cancer.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- adults (men and women) who are ≥ 18 years of age
- diagnosed with primary unilateral non-metastatic or oligometastatic breast cancer
- scheduled for surgery (mastectomy or breast conserving surgery; in combination with axillary lymph node dissection or sentinel node biopsy)
- able to read, understand, and speak Dutch
- have voluntary written informed consent of the patient
You likely can't join if
- distant metastases
- planned bilateral lymph node surgery
- oedema of the arm from another cause
- an allergy to iodine or Indocyanine Green (ICG), or
- physically or mentally unable to participate throughout the entire duration of the study
The study team makes the final eligibility decision.
Where it's taking place
- Leuven, Vlaams-Brabant, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Leuven, Vlaams-Brabant, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.